Results
2307
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2307 companies
ANI Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$59.08
7D
-2.1%
1Y
-4.2%
Ocular Therapeutix
Market Cap: US$1.2b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.30
7D
5.3%
1Y
21.7%
U.S. Physical Therapy
Market Cap: US$1.2b
Operates and manages outpatient physical therapy clinics.
USPH
US$77.28
7D
0.04%
1Y
-25.0%
Sienna Senior Living
Market Cap: CA$1.7b
Provides senior living services in Canada.
SIA
CA$17.90
7D
3.1%
1Y
20.3%
CVS Group
Market Cap: UK£892.4m
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
CVSG
UK£12.44
7D
-1.6%
1Y
20.1%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.16
7D
3.7%
1Y
-44.4%
Innoviva
Market Cap: US$1.2b
Engages in the development and commercialization of pharmaceutical products in the United States and internationally.
INVA
US$18.95
7D
5.2%
1Y
17.8%
Pulse Biosciences
Market Cap: US$1.1b
Operates as a novel bioelectric medicine company.
PLSE
US$17.30
7D
6.1%
1Y
44.9%
Natus Medical
Market Cap: US$1.1b
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
NTUS
US$32.96
7D
0.8%
1Y
34.4%
Viridian Therapeutics
Market Cap: US$1.1b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$13.66
7D
10.3%
1Y
7.6%
Aveanna Healthcare Holdings
Market Cap: US$1.1b
A diversified home care platform company, provides pediatric and adult healthcare services in the United States.
AVAH
US$5.49
7D
-5.7%
1Y
94.7%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.34
7D
6.2%
1Y
50.8%
10x Genomics
Market Cap: US$1.1b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$8.32
7D
-8.8%
1Y
-65.4%
Establishment Labs Holdings
Market Cap: US$1.1b
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$35.88
7D
-1.6%
1Y
-32.7%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.09
7D
0.2%
1Y
1.0%
Spire Healthcare Group
Market Cap: UK£793.5m
Owns and operates private hospitals and clinics in the United Kingdom.
SPI
UK£1.97
7D
-0.7%
1Y
-25.9%
MiMedx Group
Market Cap: US$1.1b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.90
7D
-0.9%
1Y
-12.1%
OPKO Health
Market Cap: US$1.1b
A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
OPK
US$1.30
7D
3.2%
1Y
-1.5%
Mineralys Therapeutics
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$16.66
7D
10.3%
1Y
33.1%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$12.92
7D
-2.0%
1Y
-37.6%
Integra LifeSciences Holdings
Market Cap: US$1.0b
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$12.69
7D
-1.8%
1Y
-54.9%
Harrow
Market Cap: US$1.0b
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$26.73
7D
6.4%
1Y
55.2%
NeoGenomics
Market Cap: US$1.0b
Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
NEO
US$7.40
7D
-7.0%
1Y
-48.8%
agilon health
Market Cap: US$1.0b
Provides healthcare services for seniors through primary care physicians in the communities of the United States.
AGL
US$2.35
7D
-12.0%
1Y
-60.8%
Evolent Health
Market Cap: US$1.0b
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$8.00
7D
-10.5%
1Y
-65.6%
Pennant Group
Market Cap: US$1.0b
Provides healthcare services in the United States.
PNTG
US$28.63
7D
-2.3%
1Y
23.8%
Wave Life Sciences
Market Cap: US$1.0b
A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.
WVE
US$6.04
7D
-4.9%
1Y
-6.2%
Gyre Therapeutics
Market Cap: US$1.0b
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$10.37
7D
-0.2%
1Y
-23.4%
Intellia Therapeutics
Market Cap: US$1.0b
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$9.20
7D
16.8%
1Y
-64.6%
Craneware
Market Cap: UK£745.9m
Develops, licenses, and supports computer software for the healthcare industry in the United States.
CRW
UK£21.30
7D
8.1%
1Y
-3.6%
Ardelyx
Market Cap: US$1.0b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.99
7D
21.6%
1Y
-49.0%
CareDx
Market Cap: US$987.8m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$17.05
7D
6.4%
1Y
9.5%
Nutex Health
Market Cap: US$986.3m
Operates as a physician-led, healthcare services, and operations company in the United States.
NUTX
US$169.00
7D
6.4%
1Y
2,214.8%
Phibro Animal Health
Market Cap: US$976.5m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$23.25
7D
-0.5%
1Y
26.3%
CureVac
Market Cap: US$963.7m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$3.90
7D
15.7%
1Y
-0.3%
Collegium Pharmaceutical
Market Cap: US$963.0m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$29.47
7D
1.4%
1Y
-13.8%